Healthcare provider profile · identity verified

Reiker Joseph Schultz, MD

Internal Medicine · SONORA, CA · NPI 1285910554

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	952	265
Levothyroxine Sodium	Levothyroxine Sodium	403	98
Losartan Potassium	Losartan Potassium	399	114
Lisinopril	Lisinopril	293	77
Amlodipine Besylate	Amlodipine Besylate	286	82
Potassium Chloride	Potassium Chloride	232	81
Omeprazole	Omeprazole	218	60
Metformin Hcl	Metformin Hcl	208	58
Metoprolol Succinate	Metoprolol Succinate	208	61
Hydrochlorothiazide	Hydrochlorothiazide	193	59
Gabapentin	Gabapentin	161	47
Trazodone Hcl	Trazodone Hcl	155	38
Tamsulosin Hcl	Tamsulosin Hcl	139	47
Furosemide	Furosemide	137	38
Pravastatin Sodium	Pravastatin Sodium	136	37
Pantoprazole Sodium	Pantoprazole Sodium	116	36
Fluoxetine Hcl	Fluoxetine Hcl	104	29
Alendronate Sodium	Alendronate Sodium	95	24
Lorazepam	Lorazepam	94	18
Spironolactone	Spironolactone	91	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	88	24
Sertraline Hcl	Sertraline Hcl	88	25
Metoprolol Tartrate	Metoprolol Tartrate	86	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	21
Allopurinol	Allopurinol	81	23
Clopidogrel	Clopidogrel Bisulfate	79	24
Duloxetine Hcl	Duloxetine Hcl	77	19
Albuterol Sulfate Hfa	Albuterol Sulfate	72	37
Atenolol	Atenolol	72	20
Eliquis	Apixaban	68	23
Ezetimibe	Ezetimibe	68	19
Paroxetine Hcl	Paroxetine Hcl	68	19
Donepezil Hcl	Donepezil Hcl	64	15
Olmesartan Medoxomil	Olmesartan Medoxomil	58	21
Rosuvastatin Calcium	Rosuvastatin Calcium	55	17
Zolpidem Tartrate	Zolpidem Tartrate	55	14
Glimepiride	Glimepiride	51	16
Estradiol	Estradiol	50	20
Ozempic	Semaglutide	48	14
Amitriptyline Hcl	Amitriptyline Hcl	47	16
Baclofen	Baclofen	46	20
Fluticasone Propionate	Fluticasone Propionate	46	21
Famotidine	Famotidine	45	13
Synthroid	Levothyroxine Sodium	43	12
Tramadol Hcl	Tramadol Hcl	41	suppressed
Carvedilol	Carvedilol	40	suppressed
Montelukast Sodium	Montelukast Sodium	40	12
Ibuprofen	Ibuprofen	39	17
Warfarin Sodium	Warfarin Sodium	39	suppressed
Propranolol Hcl	Propranolol Hcl	37	suppressed
Jardiance	Empagliflozin	36	suppressed
Acyclovir	Acyclovir	35	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Valsartan	Valsartan	35	11
Escitalopram Oxalate	Escitalopram Oxalate	34	suppressed
Myrbetriq	Mirabegron	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Celecoxib	Celecoxib	33	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Simvastatin	Simvastatin	31	11
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	27	suppressed
Cephalexin	Cephalexin	26	21
Finasteride	Finasteride	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Olanzapine	Olanzapine	24	suppressed
Klor-Con 10	Potassium Chloride	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Meloxicam	Meloxicam	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Valacyclovir	Valacyclovir Hcl	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Temazepam	Temazepam	20	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Azithromycin	Azithromycin	16	13
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Fenofibrate	Fenofibrate,micronized	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Premarin	Estrogens, Conjugated	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Colchicine	Colchicine	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	14	suppressed
Metformin Hcl Er	Metformin Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Glipizide	Glipizide	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Armodafinil	Armodafinil	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Prednisone	Prednisone	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error